Lobbying Activity Report

2603-17

Organization: Sandoz Canada Inc.
Associated registration: 2015-2603-6
Lobbying Activity date: 2020-05-11
Arranged a meeting: Yes
Posted date: 2020-05-21

In-house lobbyists who participated in the lobbying activity: John Warrington
Senior Public Office Holders who were lobbied in this activity: Lynne Nakashima, Provincial Oncology Pharmacy Director
BC Cancer, Provincial Health Services Authority
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Discuss matters related to public funding of pharmaceutical treatments that are developed, manufactured and supplied by Sandoz Canada Inc.
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
Finances and Budgets, Health
Raising awareness to government officials for generic and biosimilar products development by Sandoz Canada Inc. and the potential savings realized by the healthcare system.
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
Finances and Budgets, Health
 
Senior officer who filed this Lobbying Activity Report: Michel Robidoux
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.

Date Modified: